跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
劉 澤英
教授
生物醫學工程學系
電話
02-2826-7923
電子郵件
tyliu5
nycu.edu
tw
h-index
h10-index
h5-index
1001
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
434
引文
13
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
140
引文
6
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2025
每年研究成果
概覽
指紋
網路
研究成果
(45)
類似的個人檔案
(6)
指紋
查看啟用 Tse-Ying Liu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Carboxymethyl chitosan
94%
Superparamagnetic Iron Oxide
81%
Drug Vehicle
78%
Radiotherapy
75%
Osteosarcoma
74%
Enhanced Cancer Therapy
74%
Chitosan
57%
Drug Carrier
56%
Theranostics
55%
Protoporphyrin IX (PpIX)
55%
Bacterial Membrane Vesicles
55%
Tumor Cells
51%
Ultrasound
46%
In Vitro Study
44%
Release Behavior
44%
Photodynamic Therapy
44%
Chitosan Hydrogel
42%
Outer Membrane Vesicles
41%
Nanovehicles
39%
Magnetic Resonance Imaging
39%
Therapeutic Efficacy
39%
Radiosensitization
37%
Imaging Mechanisms
37%
Multimodal Imaging
37%
Eu Nanoparticle
37%
Growth Factors
37%
Polygalacturonic Acid
37%
Sequential Release
37%
Hyaluronate
37%
Tumor Cell Targeting
37%
Epidural Fibrosis
37%
Luminescence
37%
Glioblastoma
37%
Immunomodulation
37%
Dual Action
37%
Action Strategies
37%
Oral Cancer Treatment
37%
Rutile
37%
TiO2 Nanoparticles
37%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
37%
Metastasis
36%
Amphiphilic chitosan
35%
Targeted Radiotherapy
33%
Carboxymethylation
33%
Cartilage Tissue Engineering
33%
Nanomedicine
33%
Hyaluronic Acid Hydrogel
33%
Tumor
32%
Adjuvant Radiotherapy
32%
Hydroxyapatite Coating
32%
Medicine and Dentistry
Radiation Therapy
95%
In Vitro
77%
Restylane
68%
Tumor Cell
59%
Cancer Therapy
57%
Fibrosis
55%
Polygalacturonic Acid
37%
Osteosarcoma
37%
Glioblastoma
37%
Metastatic Carcinoma
37%
Membrane Vesicle
37%
Oral Cancer
37%
Immunomodulation
37%
Titanium Dioxide Nanoparticle
37%
Nanoparticle
34%
Nanomedicine
33%
Low Drug Dose
32%
Chitosan
31%
Adjuvant Radiotherapy
29%
Outer Membrane
27%
Silicon Dioxide
21%
Extracellular Matrix
20%
Calcium Fluoride
18%
Low Level Laser Therapy
18%
Osteoplasty
18%
Bacterium Adherence
18%
Protein Kinase C Delta
18%
Sustained Drug Release
18%
Targeted Therapy
18%
Smooth Muscle Cell
18%
Growth Factor
18%
Dental Implant
18%
Nanocage
18%
Articular Cartilage
18%
Gene Therapy
18%
Peri-Implantitis
18%
Adipose Tissue
18%
Circulating Tumor Cell
18%
Ibuprofen
18%
Immunotherapy
18%
Skin Fibrosis
18%
Breast Cancer
18%
Bone Remodeling
18%
Reactive Oxygen Species
18%
Radioprotective Agent
18%
Mouth Squamous Cell Carcinoma
18%
Intracranial Tumor
14%
Polyvinyl Alcohol
14%
Cytotoxicity
13%
Combination Therapy
13%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Chitosan
98%
Osteosarcoma
74%
Mouth Cancer
43%
Immunomodulation
37%
Titanium Dioxide Nanoparticle
37%
Glioblastoma
37%
Protoporphyrin IX
37%
Mouth Squamous Cell Carcinoma
37%
Nanoparticle
33%
Hydroxyapatite
32%
Reactive Oxygen Metabolite
31%
Drug Carrier
30%
Malignant Neoplasm
26%
Cytotoxicity
26%
Silicon Dioxide
25%
Radiosensitizing Agent
25%
Hyaluronic Acid
24%
Combination Therapy
23%
Mesoporous Silica
23%
Iron Oxide Nanoparticle
22%
Europium
21%
Metastasis
21%
Micelle
20%
Graphene Oxide
19%
Superparamagnetic Iron Oxide
18%
Hyperthermia
18%
Polysaccharide
18%
Antibiotics
18%
Ovariectomy-Induced Osteoporosis
18%
Nanomedicine
18%
Sustained Release
18%
Drug Vehicle
18%
Alginic Acid
18%
Fibrosis
18%
Gold Nanorod
18%
Deoxyglucose
18%
Sesame
18%
Nanocarrier
18%
Nanohybrid
18%
Cancer Growth
18%
Graphene Quantum Dot
18%
Radioprotective Agent
18%
Radiation Dermatitis
18%
Squamous Cell Carcinoma
18%
Growth Factor
18%
Immunotherapy
18%
Escherichia coli
18%
Nanobead
18%
Calcium Fluoride
15%
